Artificial Intelligence Across the Drug Development Lifecycle
Medical Sciences · 10.05.2026 · 14 (2) · 248
DOI: 10.3390/medsci14020248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 10.05.2026. Verfasst von Grigory Demyashkin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass., 3, 125284 Moscow, Russia. Hauptthemen laut MEDLINE: Artificial Intelligence, Drug Development, Drug Discovery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Artificial intelligence (AI) is becoming a central driver of change across the drug development lifecycle. However, its integration is evolving so rapidly that it remains essential to understand how these technologies are currently positioned within the field. Because reliable access to high-quality (effective and safe) drugs is essential to public health, the pharmaceutical product lifecycle (PPL) offers a coherent framework for evaluating how AI can enhance evidence and data creation across all stages. To understand where AI genuinely adds value, this review examines its contribution across the major stages of the PPL. Rather than treating drug discovery, nonclinical evaluation, clinical research, and post-marketing assessment as separate domains, we view them as a continuous chain of data, where digital technologies enhance different decision points in distinct ways. In early discovery, AI narrows the search space by integrating diverse datasets to prioritize candidates most likely to succeed. Nonclinical models increasingly rely on machine-learning systems designed to improve the human relevance of safety predictions. Within clinical trials, AI supports cohort formation, real-time monitoring, and new analytic strategies that supplement empirical evidence. Case studies from leading pharmaceutical companies illustrate that the most meaningful advances emerge when AI is embedded not as a standalone tool but as part of a broader data strategy that links information across stages. Taken together, current evidence suggests that AI is beginning to transform data generation and integration throughout the PPL. Given the accelerating pace of digital innovation, it is essential for the field to maintain continuous awareness of emerging methodologies and evolving regulatory frameworks to ensure that these technologies are implemented in a reliable, transparent, and scientifically grounded manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Digital Oncomorphology, National Medical Research Centre of Radiology, 2nd Botkinsky Pass., 3, 125284 Moscow, Russia.
- Department of Industrial Pharmacy, Institute of Professional Education of the I.M. Sechenov First Moscow State Medical University of the Russian Ministry of Health (Sechenov University), Trubetskaya st., 8/2, 119048 Mos…
- Department of General and Clinical Pharmacology, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya st., 6, 117198 Moscow, Russia.
- Autonomous Non-Profit Organization Association of Participants in the Circulation of Medicines and Medical Devices "Lekmedobrashchenie", 119333 Moscow, Russia.
- Department of Urology and Operative Nephrology, Peoples' Friendship University of Russia (RUDN University), Miklukho-Maklaya st., 6, 117198 Moscow, Russia.
ORCID-Profile: Grigory Demyashkin, Mikhail Parshenkov, Sergey Zyryanov
Zitieren
APA
Demyashkin, G., Parshenkov, M., Zyryanov, S., Yavorskiy, A., Shegai, P., & Kaprin, A. (2026). Artificial Intelligence Across the Drug Development Lifecycle. Medical Sciences, 14(2), 248. https://doi.org/10.3390/medsci14020248
Vancouver
Demyashkin G, Parshenkov M, Zyryanov S, Yavorskiy A, Shegai P, Kaprin A. Artificial Intelligence Across the Drug Development Lifecycle. Medical Sciences. 2026;14(2):248. doi:10.3390/medsci14020248
BibTeX
@article{Demyashkin2026,
author = {Demyashkin, Grigory and Parshenkov, Mikhail and Zyryanov, Sergey and Yavorskiy, Alexander and Shegai, Petr and Kaprin, Andrey},
title = {Artificial Intelligence Across the Drug Development Lifecycle},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {248},
doi = {10.3390/medsci14020248}
}
EUVIMED